Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.

Saved in:
Bibliographic Details
Title: Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Authors: Teerlink, J. R.1 john.teerlink@ucsf.edu, Diaz, R.2, Felker, G. M.3, McMurray, J. J. V.4, Metra, M.5, Solomon, S. D.6, Adams, K. F.7, Anand, I.8, Arias-Mendoza, A.9, Biering-Sorensen, T.10, Bohm, M.11, Bonderman, D.12, Cleland, J. G. F.13,14, Corbalan, R.15, Crespo-Leiro, M. G.16, Dahlstrom, U.17, Echeverria, L. E.18, Fang, J. C.19, Filippatos, G.20, Fonseca, C.21
Source: New England Journal of Medicine. 1/14/2021, Vol. 384 Issue 2, p105-116. 12p.
Database: Academic Search Ultimate
Description
ISSN:00284793
DOI:10.1056/NEJMoa2025797